Skip to content

Are You Prepared For Questions About Medical Cannabis?

Are You Prepared For Questions About Medical Cannabis?

With over 85% of Americans supporting legalizing medical cannabis, it’s inevitable that patients will begin asking their primary care doctors about its use and overall efficacy. Doctors and other medical professionals will be called upon to be ‘sense-makers’ for a treatment they never studied in medical school and have limited available research to draw upon.  It’s a very challenging problem made more complex by the fact that medical cannabis use in individuals 65 and older increased 75% in the last 4 years, leaving many to wonder if there are any negative effects resulting from interactions with other medications. 

We at Arfinn Med understand the complexity of this issue and have released an updated version of our software to address this gap.  In addition to our EMR, completely online patient intake process, and telehealth solutions, we now have the ability to track patient outcomes dynamically through SMS updates, a customizable patient portal, and data fields specifically for cannabis patients.  This information will help medical professionals assist their patients throughout the whole process including efficacy review data on dispensaries and product type.     

We will also allow medical professionals with split practices to embed our platform in their existing EMR software so they can query our database of deidentified efficacy data for any patient demographic or condition. This will allow our users to confidently recommend cannabis to their patients with actual point-of-care analytics while keeping cannabis patients separate from the general patient population.  This will ensure cannabis patients will receive the proper follow-up and monitoring. 

If you’re looking for easy to use practice management software and a robust EMR, please reach out to us at info@arfinnmed.com to learn how we put the power of data into your patient care.      

Stories you may be interested in

State Board of Health reviews timelines for establishing Mississippi medical marijuana program

JACKSON, Miss. (WLBT) – The blueprint for Mississippi’s medical marijuana program is Initiative 65 that voters approved in November. That contains detailed requirements and the clock is ticking to get it started. The State Board of Health met virtually Wednesday to discuss the groundwork of the medical marijuana program. “I do want to tell you…
Read More

Cannabis and Seniors

As more and more research comes out regarding the medical benefits of cannabis, it’s important to keep up with new research as it becomes available.  Here at Arfinn Med, we constantly review new studies and look at our own deidentified efficacy data to try to find any additional insights we can relay to our registered…
Read More

Study on cannabis chemical as a treatment for pancreatic cancer may have ‘major impact,’ Harvard researcher says

Pancreatic cancer makes up just 3 percent of all cancers in America. But with a one-year survival rate of just 20 percent (and five-year survival rate of less than 8), it’s predicted to be the second leading cause of cancer-related death by 2020. Headlines about the illness, as a result, tend to be discouraging. But this month scientists from Harvard University’s Dana-Farber…
Read More

New Feature: Calendar Integration

At Arfinn Med, we’re excited to announce the third feature update to join automated text messaging and note templating: calendar integration. With this addition, physicians can now integrate their Google Calendar or Calendy account. The implementation of calendar integration rounds out the Arfinn Med portal, making it a physician’s one-stop-shop EMR tool. How It Works…
Read More

$2.7 million awarded for medical marijuana research in Colorado

The state has awarded $2.7 million for research into how medical marijuana could replace opioids to ease chronic spinal pain — and how it might treat irritability in children and adolescents with autism. Read the full story here.
Read More

Florida’s largest cannabis company makes a deal to carry edible marijuana products

TALLAHASSEE The state’s first and largest medical marijuana provider, Trulieve, signed an exclusive deal to bring high-end edible marijuana products to Florida, the company announced Wednesday. Binske, the Colorado-based company, began operations just two years ago, markets “an experience” through their top-shelf products. Florida’s 162,000 registered patients will soon be able to buy and medicate…
Read More

Leave a Comment

You must be logged in to post a comment.